Tofacitinib Tablets IP – JAKBLOK-5 Manufacturing in India
JAKBLOK-5 (Tofacitinib Tablets IP) is a JAK inhibitor manufactured in India for treating rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. This immunosuppressant medication blocks specific enzymes to reduce inflammation and immune system activity. Available in precise dosages, it offers an effective treatment option for autoimmune conditions, meeting international quality standards in Indian pharmaceutical manufacturing.









